The ROE as of December 2024 (TTM) for Plus Therapeutics, Inc. (PSTV) is 271.49%

According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 271.49%. This represents a change of 144.50% compared to the average of 111.04% of the last 4 quarters.

Plus Therapeutics, Inc. (PSTV) Historical ROE (quarterly & annually)

How has PSTV ROE performed in the past?

The mean historical ROE of Plus Therapeutics, Inc. over the last ten years is -98.98%. The current 271.49% ROE has changed -374.29% with respect to the historical average. Over the past ten years (40 quarters), PSTV's ROE was at its highest in in the September 2019 quarter at 328.75%. The ROE was at its lowest in in the March 2020 quarter at -1278.82%.

Plus Therapeutics, Inc. (PSTV) ROE by Quarter and Year

Discovering the peaks and valleys of Plus Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Plus Therapeutics, Inc. (PSTV) Average ROE

How has PSTV ROE performed in the past?

The current ROE of Plus Therapeutics, Inc. (PSTV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Plus Therapeutics, Inc. (PSTV) ROE vs. Peers

How is PSTV’s ROE compared to its peers?

Plus Therapeutics, Inc.’s ROE is greater than Aditxt, Inc. (-431.38%), greater than Palisade Bio, Inc. (-148.31%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Zura Bio Limited (-39.61%), less than Altamira Therapeutics Ltd. (783.37%), greater than Immix Biopharma, Inc. (-102.10%), greater than Enveric Biosciences, Inc. (-201.01%), greater than First Wave BioPharma, Inc. (-17.85%), greater than Dermata Therapeutics, Inc. (-247.40%), less than Panbela Therapeutics, Inc. (304.71%), less than ContraFect Corporation (376.50%), greater than Protara Therapeutics, Inc. (-55.96%), less than Vaccinex, Inc. (1.93%), greater than Monopar Therapeutics Inc. (-21731.73%), greater than Miromatrix Medical Inc. (-70.01%), greater than Surrozen, Inc. (-222.75%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Hoth Therapeutics, Inc. (-89.69%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Virax Biolabs Group Limited (-115.10%),

Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.